Skip to main content
Neutralizing antibodies in multiple sclerosis patients treated with 375 microg interferon-beta-1b.
- Authors: Durelli, L; Ricci, A; Barbero, P; Cucci, A; Ferrero, B; Festa, E; Contessa, G; De Mercanti, S; Ripellino, P; Lapuma, D; Viglietta, E; Ferrero, C; Bergui, M; Versino, E; Clerico, M; Rottoli, M; Moroni, S; Teatini, F; Schoenhuber, R; Spissu, A; Reggio, A; Lo Fermo S; Liberto, A; Perla, F; Grasso, E; Montanari, E; Pesci, I; Manneschi, L; Grezzi, A; Zaffaroni, M; Carolei, A; Totaro, R; Giuliani, G; Pucci, E; Cartechini, E; Scarpini, E; Clerici, R; Protti, A; Erminio, C; Cotrufo, R; Lus, G; Savettieri, G; Salemi, G; Bergamaschi, R; Romani, A; Iudice, A; Frittelli, C; Motti, L; Marcello, N; Meola, G; Robotti, M; Cavallo, R; Ravetti, C; Deotto, L
- Publication year: 2009
- Type:
Articolo in rivista
(Articolo in rivista)
- Key words: Multiple sclerosis, interferon-beta-1b
- OA Link: http://hdl.handle.net/10447/36701